IRINA KISELEVA: Open Payments
NPI 1952533317 · ALBANY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 21 payments from 10 companies in 2025. Trend: 2023 $352 · 2024 $362 · 2025 $495
Food & beverage: $416Education: $79
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $160 |
| Exeltis, USA Inc. | 6 | $132 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $53 |
| Teleflex LLC | 1 | $26 |
| Organon LLC | 1 | $24 |
| Davol Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $21 |
| Becton, Dickinson and Company | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: SLYND, Veozah, JOURNAVX, QUIKCLOT, NEXPLANON, ARISTA, ZURZUVAE, BD Onclarity.
Industry payments across OR — which companies pay providers there.
